Global Fecal Management System Market
Global Fecal Management System Market

Fecal Management System Comprehensive Study by Patient Type (Adult, Pediatric), Product (Colostomy Bags, Irrigation System, Nerve Modulation Devices, Accessories), End-User (Home Care, Hospitals, Ambulatory Surgery Centers) Players and Region - Global Market Outlook to 2027

Fecal Management System Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 202 Pages 219 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Fecal Management System?
A fecal management system (FMS) is a completely closed system that collects and holds liquid or semi-liquid stools and can help prevent fecal pollution of the environment. In individuals with little or no bowel control, is used to protect the patient's skin and reduce exposure to infectious bacteria. These methods are intended to prevent infections and cut down on the number of time nurses spend on the job. For elderly persons and patients suffering from constipation or fecal incontinence, stool management systems are beneficial. It is also beneficial for bedridden people who have suffered from illnesses such as strokes, paralysis, or spinal injuries. Stool management systems help hospitals save money by lowering nurse time and other costs.

The market study is broken down and major geographies with country level break-up.

The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market in the near future. Players are anticipated to focus on the development of new systems, which is likely to encourage the growth of the global market throughout the forecast period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Torbot Group Jobskin (United States), C. R. Bard (United States), Hollister Incorporated (United States), Marlen Manufacturing (United States), Nuvomed (United States), ConvaTec, Inc (United Kingdom), Prosyn International Ltd (United Kingdom), Becton Dickinson (United States), Primed Halberstadt Medizintechnik GmbH (Germany), Meridian Bioscience (United States) and Torbot Group Jobskin (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Fecal Management System market by Type, Application and Region.

On the basis of geography, the market of Fecal Management System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Patient Type, the sub-segment i.e. Adult will boost the Fecal Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product, the sub-segment i.e. Colostomy Bags will boost the Fecal Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Home Care will boost the Fecal Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In August 2020 - B. Braun Medical Inc. (B. Braun) and Kerma Medical Goods, Inc. (Kerma) have established a partnership aimed at improving the development and delivery of healthcare products and services, particularly for veterans, minorities, and other underrepresented groups.



Market Trend
  • Increasing the Number of Bed Ridden Patients That Need Nursing

Market Drivers
  • Favorable Reimbursement Scenario in Developed Countries
  • The increasing widespread incidence of diarrhea

Opportunities
  • Healthcare Spending Consistently Rising in Developed Countries
  • The population of geriatrics is on the rise globally

Restraints
  • Due to the social shame associated with bowel disorders, the majority of fecal incontinence (FI) occurrences go unreported by patients.

Challenges
  • Patients Try To Hide Diarrhea and This Type of Problem to Avoid Dependency on Others
  • The Prevalence Of Fecal Incontinence Can Be Difficult To Determine As It Relies On Patient Self-Reporting And Is Often Underreported


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Hospitals, End-User Industries and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Torbot Group Jobskin (United States), C. R. Bard (United States), Hollister Incorporated (United States), Marlen Manufacturing (United States), Nuvomed (United States), ConvaTec, Inc (United Kingdom), Prosyn International Ltd (United Kingdom), Becton Dickinson (United States), Primed Halberstadt Medizintechnik GmbH (Germany), Meridian Bioscience (United States) and Torbot Group Jobskin (United States) etc.

2. Can we have customized study for Fecal Management System Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Fecal Management System Market by 2027?
Analysts at AMA estimates Fecal Management System Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By Patient Type
  • Adult
  • Pediatric

By Product
  • Colostomy Bags
  • Irrigation System
  • Nerve Modulation Devices
  • Accessories

By End-User
  • Home Care
  • Hospitals
  • Ambulatory Surgery Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Favorable Reimbursement Scenario in Developed Countries
      • 3.2.2. The increasing widespread incidence of diarrhea
    • 3.3. Market Challenges
      • 3.3.1. Patients Try To Hide Diarrhea and This Type of Problem to Avoid Dependency on Others
      • 3.3.2. The Prevalence Of Fecal Incontinence Can Be Difficult To Determine As It Relies On Patient Self-Reporting And Is Often Underreported
    • 3.4. Market Trends
      • 3.4.1. Increasing the Number of Bed Ridden Patients That Need Nursing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fecal Management System, by Patient Type, Product, End-User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Fecal Management System (Value)
      • 5.2.1. Global Fecal Management System by: Patient Type (Value)
        • 5.2.1.1. Adult
        • 5.2.1.2. Pediatric
      • 5.2.2. Global Fecal Management System by: Product (Value)
        • 5.2.2.1. Colostomy Bags
        • 5.2.2.2. Irrigation System
        • 5.2.2.3. Nerve Modulation Devices
        • 5.2.2.4. Accessories
      • 5.2.3. Global Fecal Management System Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Australia
          • 5.2.3.2.6. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Fecal Management System (Price)
  • 6. Fecal Management System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Torbot Group Jobskin (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. C. R. Bard (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hollister Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Marlen Manufacturing (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nuvomed (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ConvaTec, Inc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Prosyn International Ltd (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Becton Dickinson (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Primed Halberstadt Medizintechnik GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Meridian Bioscience (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Torbot Group Jobskin (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Fecal Management System Sale, by Patient Type, Product, End-User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Fecal Management System (Value)
      • 7.2.1. Global Fecal Management System by: Patient Type (Value)
        • 7.2.1.1. Adult
        • 7.2.1.2. Pediatric
      • 7.2.2. Global Fecal Management System by: Product (Value)
        • 7.2.2.1. Colostomy Bags
        • 7.2.2.2. Irrigation System
        • 7.2.2.3. Nerve Modulation Devices
        • 7.2.2.4. Accessories
      • 7.2.3. Global Fecal Management System Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Australia
          • 7.2.3.2.6. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Fecal Management System (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fecal Management System: by Patient Type(USD Million)
  • Table 2. Fecal Management System Adult , by Region USD Million (2016-2021)
  • Table 3. Fecal Management System Pediatric , by Region USD Million (2016-2021)
  • Table 4. Fecal Management System: by Product(USD Million)
  • Table 5. Fecal Management System Colostomy Bags , by Region USD Million (2016-2021)
  • Table 6. Fecal Management System Irrigation System , by Region USD Million (2016-2021)
  • Table 7. Fecal Management System Nerve Modulation Devices , by Region USD Million (2016-2021)
  • Table 8. Fecal Management System Accessories , by Region USD Million (2016-2021)
  • Table 9. South America Fecal Management System, by Country USD Million (2016-2021)
  • Table 10. South America Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 11. South America Fecal Management System, by Product USD Million (2016-2021)
  • Table 12. South America Fecal Management System, by End-User USD Million (2016-2021)
  • Table 13. Brazil Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 14. Brazil Fecal Management System, by Product USD Million (2016-2021)
  • Table 15. Brazil Fecal Management System, by End-User USD Million (2016-2021)
  • Table 16. Argentina Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 17. Argentina Fecal Management System, by Product USD Million (2016-2021)
  • Table 18. Argentina Fecal Management System, by End-User USD Million (2016-2021)
  • Table 19. Rest of South America Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 20. Rest of South America Fecal Management System, by Product USD Million (2016-2021)
  • Table 21. Rest of South America Fecal Management System, by End-User USD Million (2016-2021)
  • Table 22. Asia Pacific Fecal Management System, by Country USD Million (2016-2021)
  • Table 23. Asia Pacific Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 24. Asia Pacific Fecal Management System, by Product USD Million (2016-2021)
  • Table 25. Asia Pacific Fecal Management System, by End-User USD Million (2016-2021)
  • Table 26. China Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 27. China Fecal Management System, by Product USD Million (2016-2021)
  • Table 28. China Fecal Management System, by End-User USD Million (2016-2021)
  • Table 29. Japan Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 30. Japan Fecal Management System, by Product USD Million (2016-2021)
  • Table 31. Japan Fecal Management System, by End-User USD Million (2016-2021)
  • Table 32. India Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 33. India Fecal Management System, by Product USD Million (2016-2021)
  • Table 34. India Fecal Management System, by End-User USD Million (2016-2021)
  • Table 35. South Korea Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 36. South Korea Fecal Management System, by Product USD Million (2016-2021)
  • Table 37. South Korea Fecal Management System, by End-User USD Million (2016-2021)
  • Table 38. Australia Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 39. Australia Fecal Management System, by Product USD Million (2016-2021)
  • Table 40. Australia Fecal Management System, by End-User USD Million (2016-2021)
  • Table 41. Rest of Asia-Pacific Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 42. Rest of Asia-Pacific Fecal Management System, by Product USD Million (2016-2021)
  • Table 43. Rest of Asia-Pacific Fecal Management System, by End-User USD Million (2016-2021)
  • Table 44. Europe Fecal Management System, by Country USD Million (2016-2021)
  • Table 45. Europe Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 46. Europe Fecal Management System, by Product USD Million (2016-2021)
  • Table 47. Europe Fecal Management System, by End-User USD Million (2016-2021)
  • Table 48. Germany Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 49. Germany Fecal Management System, by Product USD Million (2016-2021)
  • Table 50. Germany Fecal Management System, by End-User USD Million (2016-2021)
  • Table 51. France Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 52. France Fecal Management System, by Product USD Million (2016-2021)
  • Table 53. France Fecal Management System, by End-User USD Million (2016-2021)
  • Table 54. Italy Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 55. Italy Fecal Management System, by Product USD Million (2016-2021)
  • Table 56. Italy Fecal Management System, by End-User USD Million (2016-2021)
  • Table 57. United Kingdom Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 58. United Kingdom Fecal Management System, by Product USD Million (2016-2021)
  • Table 59. United Kingdom Fecal Management System, by End-User USD Million (2016-2021)
  • Table 60. Netherlands Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 61. Netherlands Fecal Management System, by Product USD Million (2016-2021)
  • Table 62. Netherlands Fecal Management System, by End-User USD Million (2016-2021)
  • Table 63. Rest of Europe Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 64. Rest of Europe Fecal Management System, by Product USD Million (2016-2021)
  • Table 65. Rest of Europe Fecal Management System, by End-User USD Million (2016-2021)
  • Table 66. MEA Fecal Management System, by Country USD Million (2016-2021)
  • Table 67. MEA Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 68. MEA Fecal Management System, by Product USD Million (2016-2021)
  • Table 69. MEA Fecal Management System, by End-User USD Million (2016-2021)
  • Table 70. Middle East Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 71. Middle East Fecal Management System, by Product USD Million (2016-2021)
  • Table 72. Middle East Fecal Management System, by End-User USD Million (2016-2021)
  • Table 73. Africa Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 74. Africa Fecal Management System, by Product USD Million (2016-2021)
  • Table 75. Africa Fecal Management System, by End-User USD Million (2016-2021)
  • Table 76. North America Fecal Management System, by Country USD Million (2016-2021)
  • Table 77. North America Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 78. North America Fecal Management System, by Product USD Million (2016-2021)
  • Table 79. North America Fecal Management System, by End-User USD Million (2016-2021)
  • Table 80. United States Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 81. United States Fecal Management System, by Product USD Million (2016-2021)
  • Table 82. United States Fecal Management System, by End-User USD Million (2016-2021)
  • Table 83. Canada Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 84. Canada Fecal Management System, by Product USD Million (2016-2021)
  • Table 85. Canada Fecal Management System, by End-User USD Million (2016-2021)
  • Table 86. Mexico Fecal Management System, by Patient Type USD Million (2016-2021)
  • Table 87. Mexico Fecal Management System, by Product USD Million (2016-2021)
  • Table 88. Mexico Fecal Management System, by End-User USD Million (2016-2021)
  • Table 89. Company Basic Information, Sales Area and Its Competitors
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Company Basic Information, Sales Area and Its Competitors
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Fecal Management System: by Patient Type(USD Million)
  • Table 101. Fecal Management System Adult , by Region USD Million (2022-2027)
  • Table 102. Fecal Management System Pediatric , by Region USD Million (2022-2027)
  • Table 103. Fecal Management System: by Product(USD Million)
  • Table 104. Fecal Management System Colostomy Bags , by Region USD Million (2022-2027)
  • Table 105. Fecal Management System Irrigation System , by Region USD Million (2022-2027)
  • Table 106. Fecal Management System Nerve Modulation Devices , by Region USD Million (2022-2027)
  • Table 107. Fecal Management System Accessories , by Region USD Million (2022-2027)
  • Table 108. South America Fecal Management System, by Country USD Million (2022-2027)
  • Table 109. South America Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 110. South America Fecal Management System, by Product USD Million (2022-2027)
  • Table 111. South America Fecal Management System, by End-User USD Million (2022-2027)
  • Table 112. Brazil Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 113. Brazil Fecal Management System, by Product USD Million (2022-2027)
  • Table 114. Brazil Fecal Management System, by End-User USD Million (2022-2027)
  • Table 115. Argentina Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 116. Argentina Fecal Management System, by Product USD Million (2022-2027)
  • Table 117. Argentina Fecal Management System, by End-User USD Million (2022-2027)
  • Table 118. Rest of South America Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 119. Rest of South America Fecal Management System, by Product USD Million (2022-2027)
  • Table 120. Rest of South America Fecal Management System, by End-User USD Million (2022-2027)
  • Table 121. Asia Pacific Fecal Management System, by Country USD Million (2022-2027)
  • Table 122. Asia Pacific Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 123. Asia Pacific Fecal Management System, by Product USD Million (2022-2027)
  • Table 124. Asia Pacific Fecal Management System, by End-User USD Million (2022-2027)
  • Table 125. China Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 126. China Fecal Management System, by Product USD Million (2022-2027)
  • Table 127. China Fecal Management System, by End-User USD Million (2022-2027)
  • Table 128. Japan Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 129. Japan Fecal Management System, by Product USD Million (2022-2027)
  • Table 130. Japan Fecal Management System, by End-User USD Million (2022-2027)
  • Table 131. India Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 132. India Fecal Management System, by Product USD Million (2022-2027)
  • Table 133. India Fecal Management System, by End-User USD Million (2022-2027)
  • Table 134. South Korea Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 135. South Korea Fecal Management System, by Product USD Million (2022-2027)
  • Table 136. South Korea Fecal Management System, by End-User USD Million (2022-2027)
  • Table 137. Australia Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 138. Australia Fecal Management System, by Product USD Million (2022-2027)
  • Table 139. Australia Fecal Management System, by End-User USD Million (2022-2027)
  • Table 140. Rest of Asia-Pacific Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 141. Rest of Asia-Pacific Fecal Management System, by Product USD Million (2022-2027)
  • Table 142. Rest of Asia-Pacific Fecal Management System, by End-User USD Million (2022-2027)
  • Table 143. Europe Fecal Management System, by Country USD Million (2022-2027)
  • Table 144. Europe Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 145. Europe Fecal Management System, by Product USD Million (2022-2027)
  • Table 146. Europe Fecal Management System, by End-User USD Million (2022-2027)
  • Table 147. Germany Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 148. Germany Fecal Management System, by Product USD Million (2022-2027)
  • Table 149. Germany Fecal Management System, by End-User USD Million (2022-2027)
  • Table 150. France Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 151. France Fecal Management System, by Product USD Million (2022-2027)
  • Table 152. France Fecal Management System, by End-User USD Million (2022-2027)
  • Table 153. Italy Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 154. Italy Fecal Management System, by Product USD Million (2022-2027)
  • Table 155. Italy Fecal Management System, by End-User USD Million (2022-2027)
  • Table 156. United Kingdom Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 157. United Kingdom Fecal Management System, by Product USD Million (2022-2027)
  • Table 158. United Kingdom Fecal Management System, by End-User USD Million (2022-2027)
  • Table 159. Netherlands Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 160. Netherlands Fecal Management System, by Product USD Million (2022-2027)
  • Table 161. Netherlands Fecal Management System, by End-User USD Million (2022-2027)
  • Table 162. Rest of Europe Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 163. Rest of Europe Fecal Management System, by Product USD Million (2022-2027)
  • Table 164. Rest of Europe Fecal Management System, by End-User USD Million (2022-2027)
  • Table 165. MEA Fecal Management System, by Country USD Million (2022-2027)
  • Table 166. MEA Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 167. MEA Fecal Management System, by Product USD Million (2022-2027)
  • Table 168. MEA Fecal Management System, by End-User USD Million (2022-2027)
  • Table 169. Middle East Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 170. Middle East Fecal Management System, by Product USD Million (2022-2027)
  • Table 171. Middle East Fecal Management System, by End-User USD Million (2022-2027)
  • Table 172. Africa Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 173. Africa Fecal Management System, by Product USD Million (2022-2027)
  • Table 174. Africa Fecal Management System, by End-User USD Million (2022-2027)
  • Table 175. North America Fecal Management System, by Country USD Million (2022-2027)
  • Table 176. North America Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 177. North America Fecal Management System, by Product USD Million (2022-2027)
  • Table 178. North America Fecal Management System, by End-User USD Million (2022-2027)
  • Table 179. United States Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 180. United States Fecal Management System, by Product USD Million (2022-2027)
  • Table 181. United States Fecal Management System, by End-User USD Million (2022-2027)
  • Table 182. Canada Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 183. Canada Fecal Management System, by Product USD Million (2022-2027)
  • Table 184. Canada Fecal Management System, by End-User USD Million (2022-2027)
  • Table 185. Mexico Fecal Management System, by Patient Type USD Million (2022-2027)
  • Table 186. Mexico Fecal Management System, by Product USD Million (2022-2027)
  • Table 187. Mexico Fecal Management System, by End-User USD Million (2022-2027)
  • Table 188. Research Programs/Design for This Report
  • Table 189. Key Data Information from Secondary Sources
  • Table 190. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fecal Management System: by Patient Type USD Million (2016-2021)
  • Figure 5. Global Fecal Management System: by Product USD Million (2016-2021)
  • Figure 6. South America Fecal Management System Share (%), by Country
  • Figure 7. Asia Pacific Fecal Management System Share (%), by Country
  • Figure 8. Europe Fecal Management System Share (%), by Country
  • Figure 9. MEA Fecal Management System Share (%), by Country
  • Figure 10. North America Fecal Management System Share (%), by Country
  • Figure 11. Global Fecal Management System share by Players 2021 (%)
  • Figure 12. Global Fecal Management System share by Players (Top 3) 2021(%)
  • Figure 13. Global Fecal Management System share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Torbot Group Jobskin (United States) Revenue, Net Income and Gross profit
  • Figure 16. Torbot Group Jobskin (United States) Revenue: by Geography 2021
  • Figure 17. C. R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 18. C. R. Bard (United States) Revenue: by Geography 2021
  • Figure 19. Hollister Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 20. Hollister Incorporated (United States) Revenue: by Geography 2021
  • Figure 21. Marlen Manufacturing (United States) Revenue, Net Income and Gross profit
  • Figure 22. Marlen Manufacturing (United States) Revenue: by Geography 2021
  • Figure 23. Nuvomed (United States) Revenue, Net Income and Gross profit
  • Figure 24. Nuvomed (United States) Revenue: by Geography 2021
  • Figure 25. ConvaTec, Inc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. ConvaTec, Inc (United Kingdom) Revenue: by Geography 2021
  • Figure 27. Prosyn International Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Prosyn International Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 29. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 30. Becton Dickinson (United States) Revenue: by Geography 2021
  • Figure 31. Primed Halberstadt Medizintechnik GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Primed Halberstadt Medizintechnik GmbH (Germany) Revenue: by Geography 2021
  • Figure 33. Meridian Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 34. Meridian Bioscience (United States) Revenue: by Geography 2021
  • Figure 35. Torbot Group Jobskin (United States) Revenue, Net Income and Gross profit
  • Figure 36. Torbot Group Jobskin (United States) Revenue: by Geography 2021
  • Figure 37. Global Fecal Management System: by Patient Type USD Million (2022-2027)
  • Figure 38. Global Fecal Management System: by Product USD Million (2022-2027)
  • Figure 39. South America Fecal Management System Share (%), by Country
  • Figure 40. Asia Pacific Fecal Management System Share (%), by Country
  • Figure 41. Europe Fecal Management System Share (%), by Country
  • Figure 42. MEA Fecal Management System Share (%), by Country
  • Figure 43. North America Fecal Management System Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Torbot Group Jobskin (United States)
  • C. R. Bard (United States)
  • Hollister Incorporated (United States)
  • Marlen Manufacturing (United States)
  • Nuvomed (United States)
  • ConvaTec, Inc (United Kingdom)
  • Prosyn International Ltd (United Kingdom)
  • Becton Dickinson (United States)
  • Primed Halberstadt Medizintechnik GmbH (Germany)
  • Meridian Bioscience (United States)
  • Torbot Group Jobskin (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation